We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.20 | 14.81% | 1.55 | 1.50 | 1.60 | 1.60 | 1.35 | 1.35 | 1,778,188 | 10:24:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.43 | 2.1M |
TIDMPYC
RNS Number : 4987M
Physiomics PLC
31 July 2017
Physiomics plc
("Physiomics") or ("the Company")
Two new pre-clinical contracts
Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has today signed two new contracts with a global pharma company for Virtual Tumour pre-clinical predictions relating to a new oncology target. This marks the sixth year of collaboration with this company since a first pre-clinical project was announced in March 2012.
The two contracts will be executed in parallel between now and the end of the calendar year.
Jim Millen, CEO said: "We are delighted by these new contracts which we believe are a sign of the client's long-term commitment to Physiomics and its Virtual Tumour technology. We look forward to continuing to work closely with them going forwards".
This announcement refers to a contract in the ordinary course of business for Physiomics.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
WH Ireland Limited (nomad)
Katy Mitchell
+44 (0) 161 832 2174
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
This information is provided by RNS
The company news service from the London Stock Exchange
END
CNTLLFVRDEITFID
(END) Dow Jones Newswires
July 31, 2017 02:00 ET (06:00 GMT)
1 Year Physiomics Chart |
1 Month Physiomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions